LMCPX
Price
$32.78
Change
+$0.13 (+0.40%)
Updated
Oct 3 closing price
Net Assets
1.14B
MVCAX
Price
$32.44
Change
+$0.22 (+0.68%)
Updated
Oct 3 closing price
Net Assets
17.24B
Interact to see
Advertisement

LMCPX vs MVCAX

Header iconLMCPX vs MVCAX Comparison
Open Charts LMCPX vs MVCAXBanner chart's image
Lord Abbett Mid Cap Stock P
Price$32.78
Change+$0.13 (+0.40%)
VolumeN/A
Net Assets1.14B
MFS Mid Cap Value A
Price$32.44
Change+$0.22 (+0.68%)
VolumeN/A
Net Assets17.24B
LMCPX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
LMCPX vs. MVCAX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCPX is a Hold and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.2B vs. LMCPX (1.14B). MVCAX pays higher dividends than LMCPX: MVCAX (0.84) vs LMCPX (0.36). LMCPX was incepted earlier than MVCAX: LMCPX (28 years) vs MVCAX (24 years). LMCPX (1.23) is less costly to investors than MVCAX (1.00). LMCPX is a more actively managed with annual turnover of: 53.00 vs. MVCAX (27.00). LMCPX has a lower initial minimum investment than MVCAX: LMCPX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : -4.63 vs. LMCPX (-7.22). MVCAX return over 5 years is better than : 53.86 vs. LMCPX (42.21).
LMCPXMVCAXLMCPX / MVCAX
Total Expense Ratio1.230.99124%
Annual Report Gross Expense Ratio1.231.00123%
Fund Existence28 years24 years-
Gain YTD1.4865.73726%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B17.2B7%
Annual Yield % from dividends0.360.8443%
Returns for 1 year-7.22-4.63156%
Returns for 3 years20.6620.7899%
Returns for 5 years42.2153.8678%
Returns for 10 years40.9078.4852%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVCNF0.18N/A
+0.88%
Avicanna Inc.
IPHYF2.00N/A
N/A
Innate Pharma
OSSUY4.00N/A
N/A
EMBLA MEDICAL
SIEVF191.00N/A
N/A
D IETEREN GROUP NV
NBKCF19.16N/A
N/A
National Bank of Canada